AMANDA R SCHIEFER
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism JACKSON, MS NPI 1477563104
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism MS Novo Nordisk AS All categories
General Payments — all program years on this page
$237,399.15
- Category: General Payments
- Program years: PY2018–2024
- Record count: 580
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $5,847.66 across 39 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,128.50 | 7 |
| Food and Beverage | $719.16 | 32 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $5,250.12 | 10 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $119.19 | 1 |
| Lilly USA, LLC | $80.83 | 5 |
| Corcept Therapeutics | $69.68 | 4 |
| Medtronic, Inc. | $62.32 | 4 |
| Amgen Inc. | $36.14 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $34.83 | 2 |
| ABBVIE INC. | $34.15 | 2 |
| PFIZER INC. | $28.22 | 2 |
| Xeris Pharmaceuticals, Inc. | $21.42 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.37 | 1 |
| DEXCOM, INC. | $21.34 | 1 |
| SANOFI-AVENTIS U.S. LLC | $17.99 | 1 |
| Kyowa Kirin, Inc. | $17.63 | 1 |
| Acella Pharmaceuticals, LLC | $16.26 | 1 |
| Tandem Diabetes Care, Inc. | $16.17 | 1 |
By program year
Records — PY2024 (39)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.